BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 19504818)

  • 1. [Challenging pharmacotherapy in dementia].
    Ihl R
    MMW Fortschr Med; 2009 Mar; 151(13):46-8. PubMed ID: 19504818
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of acetaminophen on behavior, well-being, and psychotropic medication use in nursing home residents with moderate-to-severe dementia.
    Chibnall JT; Tait RC; Harman B; Luebbert RA
    J Am Geriatr Soc; 2005 Nov; 53(11):1921-9. PubMed ID: 16274373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dementia.
    Warner J; Butler R
    Clin Evid; 2002 Jun; (7):846-66. PubMed ID: 12230710
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of impaired cognition with nootropic drugs: nicergoline versus the state of the art.
    Fariello RG
    Funct Neurol; 1997; 12(3-4):221-5. PubMed ID: 9218984
    [No Abstract]   [Full Text] [Related]  

  • 5. Activities of daily living as an outcome measure in clinical trials of dementia drugs. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.
    Gauthier S; Bodick N; Erzigkeit E; Feldman H; Geldmacher DS; Huff J; Mohs R; Orgogozo JM; Rogers S
    Alzheimer Dis Assoc Disord; 1997; 11 Suppl 3():6-7. PubMed ID: 9305507
    [No Abstract]   [Full Text] [Related]  

  • 6. Outcomes for clinical trials in mild-to-moderate dementia to evaluate drugs with presumably symptomatic effects.
    Frolich L
    J Nutr Health Aging; 2007; 11(4):357-8. PubMed ID: 17653499
    [No Abstract]   [Full Text] [Related]  

  • 7. Galantamine for Alzheimer's disease and mild cognitive impairment.
    Cusi C; Cantisani TA; Celani MG; Incorvaia B; Righetti E; Candelise L;
    Neuroepidemiology; 2007; 28(2):116-7. PubMed ID: 17409773
    [No Abstract]   [Full Text] [Related]  

  • 8. [Final IQWiG to Ginkgo biloba].
    Winckler T
    Pharm Unserer Zeit; 2009; 38(5):454-61. PubMed ID: 19711323
    [No Abstract]   [Full Text] [Related]  

  • 9. Dementia.
    Warner J; Butler R; Jackson E
    Clin Evid; 2002 Dec; (8):927-50. PubMed ID: 12603921
    [No Abstract]   [Full Text] [Related]  

  • 10. Behavior as an efficacy outcome.
    Cummings JL
    Alzheimer Dis Assoc Disord; 1997; 11 Suppl 4():v-vi. PubMed ID: 9339265
    [No Abstract]   [Full Text] [Related]  

  • 11. Comprehensive approach of donepezil and psychosocial interventions on cognitive function and quality of life for Alzheimer's disease: the Osaki-Tajiri Project.
    Meguro M; Kasai M; Akanuma K; Ishii H; Yamaguchi S; Meguro K
    Age Ageing; 2008 Jul; 37(4):469-73. PubMed ID: 18515851
    [No Abstract]   [Full Text] [Related]  

  • 12. [The pharmacotherapy of the cognitive disorders in Alzheimer's disease. Guidelines for rational drug use--a review].
    Strnad J; Bahro M
    Dtsch Med Wochenschr; 2000 Jul; 125(27):835-9. PubMed ID: 10929539
    [No Abstract]   [Full Text] [Related]  

  • 13. [Challenging pharmacotherapy in dementia].
    Supprian T
    MMW Fortschr Med; 2008 May; 150 Suppl 2():33-6. PubMed ID: 18678049
    [No Abstract]   [Full Text] [Related]  

  • 14. Drugs influencing cognitive function.
    Kuruvilla A; Devi V
    Indian J Physiol Pharmacol; 1994 Oct; 38(4):241-51. PubMed ID: 7883287
    [No Abstract]   [Full Text] [Related]  

  • 15. [Advantages in long-term treatment with Cognex in Alzheimer disease].
    Gracon S; Smith F; Shokry A
    Praxis (Bern 1994); 1997 Aug; 86(35):1350-4. PubMed ID: 9381027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Reality of pharmacotherapy in nursing home patients with dementia. Results of a new field study of 23 nursing homes].
    Hallauer J
    Krankenpfl J; 2005; 43(7-10):206. PubMed ID: 16515277
    [No Abstract]   [Full Text] [Related]  

  • 17. Tense prescriptions? Alzheimer medications and the anthropology of uncertainty.
    Leibing A
    Transcult Psychiatry; 2009 Mar; 46(1):180-206. PubMed ID: 19293285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [What do nurses expect from therapy of Alzheimer disease].
    Riesner C
    Krankenpfl J; 2005; 43(7-10):209. PubMed ID: 16515280
    [No Abstract]   [Full Text] [Related]  

  • 19. [Psychobehavioral disorders in severe dementia].
    Derouesné C
    Psychol Neuropsychiatr Vieil; 2005 Mar; 3 Suppl 1():S5-13. PubMed ID: 15899600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Nootropic drugs: definition, classification, mechanism of action, clinical effectiveness, substances].
    Kuhlmey J
    Z Arztl Fortbild (Jena); 1994 Sep; 88(9):697-701. PubMed ID: 7975756
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.